|
⚲
|
| Keyboard |
| Aisling Capital Management LP
✚
|
|
|---|---|
| CRD # | 269994 |
| SEC # | 801-106625 |
| CIK # | 0001571076, 0001766721 |
| AUM | 716.4 M (2026-03-27) |
| Employees | 12 (67% Investors, 0% Brokers) |
| Phone | 212-651-6380 |
| Address | 489 Fifth Avenue New York, NY 10017 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Bridgebio Pharma Inc | 378.0 | ||
| Syndax Pharmaceuticals Inc | 30.8 | ||
| Monte Rosa Therapeutics Inc | 25.6 | ||
| Bicara Therapeutics Inc | 11.3 | ||
| Helix Acquisition Corp II | 9.1 | ||
| Compass Pathways PLC | 7.9 | ||
| Scholar Rock Holding Corp | 3.8 | ||
| Biomea Fusion Inc | 3.1 | ||
| Eupraxia Pharmaceuticals Inc | 2.4 | ||
| UroGen Pharma Ltd | 1.9 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Aisling Capital V LP | [2020-03-30] | 144.2 M | 210.0 M |
| Filed 2020-06-25 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $123,000 · Revenue Decline to Disclose | ||||
| PE | Aisling Capital IV LP | [2015-08-31] | 143.1 M | 506.4 M |
| Offered $400,000,000 · Filed 2016-07-18 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1 · Remaining $256,900,000 · Duration One year or less · Commission $5,470,000 · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 2 | 716.4 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 2 | 716.4 |
| By Discretionary | ||
| Discretionary | 2 | 716.4 |
| Non-Discretionary | 0 | 0.0 |
| Total | 2 | 716.4 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 716.4 | |
| Total | 2 | 716.4 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Steven Elms | Executive Officer | 40 | 2 | |
| Andrew Schiff | Executive Officer | 16 | 2 | |
| Aisling Capital Partners V LP | Executive Officer | 1 | 1 | |
| Aisling Capital Partners IV LLC | Executive Officer | 1 | 1 | |
| Aisling Capital Partners IV LP | Executive Officer | 1 | 1 | |
| Aisling Capital Partners V LLC | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001571076] | |
| 13F-HR | [0001766721] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Comparable Firms | State | AUM |
|---|---|---|
|
Pike Street Capital LP
✚
|
WA | 727.4 M |
|
TRGP Investment Partners LP
✚
|
CT | 726.8 M |
|
Haddington Ventures LLC
✚
|
TX | 726.4 M |
|
Union Capital Associates LP
✚
|
CT | 721.5 M |
|
Brydon Group LLC
✚
|
DC | 721.5 M |
|
ParkerGale LLC
✚
|
IL | 719.1 M |
|
Grant Avenue Capital LLC
✚
|
NY | 716.1 M |
|
Bench Walk Advisors LLC
✚
|
FL | 707.6 M |
|
Lincoln Peak Capital Management LLC
✚
|
MA | 706.5 M |
|
Latticework Capital Management LLC
✚
|
TX | 705.1 M |